---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-066819"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:13:04.515043+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Oramed grants Scilex option to repurchase Penny Warrants for up to $27M; clarifies warrant terms

## Summary
- Scilex pays $1.5M option fee in two installments ($750K by Aug 8, 2025; $750K by Dec 16, 2025).
- Scilex may repurchase 3.13M warrants for $13M by Sep 30, 2025, and 3.37M warrants for $14M by Dec 31, 2025.
- If all payments made, Tranche A Note maturity extends to Mar 31, 2026, and make-whole payment waived.
- Oramed clarifies Penny Warrant exercise price remains $0.01/share post 1-for-35 reverse split, not $0.35.
- Correction has no impact on financial position, results, or cash flows as of Mar 31, 2025.

## SEC filing metadata
- accession: 0001213900-25-066819
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390025066819/0001213900-25-066819-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390025066819/ea0248817-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-066819
- JSON: https://secwatch.observer/filing/0001213900-25-066819.json
- Plain text: https://secwatch.observer/filing/0001213900-25-066819.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.